Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus

Código QR

Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus

Oana Albai,1,2 Bogdan Timar,2,3 Diana Loreta Paun,4 Alexandra Sima,1,2 Deiana Roman,1,2 Romulus Timar1,2 1Second Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania; 2Department of Diabetes and Metabolic Diseases, “Piu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Albai O, Timar B, Paun DL, Sima A, Roman D, Timar R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	megaloblastic anemia metformin vitamin b12 deficiency Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/5565747a7a944b34b839c1e3a9a3b479
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

DIAGNOSTIC UTILITY OF SERUM LACTATE DEHYDROGENASE LEVELS (LDL) IN DIFFERENTIATING MEGALOBLASTIC ANEMIA FROM MYELODYSPLASTIC SYNDROMES IN PAKISTAN
por: Faraz Ali Rana, et al.
Publicado: (2021)

Chronic Autoimmune Gastritis: Modern Diagnostic Principles
por: Maria A. Livzan, et al.
Publicado: (2021)

Assessment of Serum Vitamin B12 and Folate Levels and Macrocytosis in Patients with Type 2 Diabetes Mellitus on Metformin Attending Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study
por: Wale Tesega W, et al.
Publicado: (2021)

ASSOCIATION OF VITAMIN B12 DEFICIENCY AND METFORMIN USE IN PATIENTS PRESENTING WITH TYPE II DIABETES MELLITUS
por: Karamat Ali, et al.
Publicado: (2020)

Long‐term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome
por: Albai O, et al.
Publicado: (2020)

Do we need to measure vitamin B12 and magnesium in morbidly obese patients with type 2 diabetes mellitus?
por: Wåhlén A, et al.
Publicado: (2017)

Déficit de vitamina B-12 en adultos mayores: ¿Un problema de salud pública en Chile?
por: SÁNCHEZ,HUGO, et al.
Publicado: (2010)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang Q, et al.
Publicado: (2020)

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
por: Xie J, et al.
Publicado: (2019)

Vitamin B12 Deficiency Resembling Acute Leukemia: A Case Report
por: Nisha Sharma, et al.
Publicado: (2021)

The Mental Status in Patients with Diabetes Mellitus Admitted to a Diabetes Clinic After Presenting in the Emergency Room: The Application of the SCL-90 Scale
por: Albai O, et al.
Publicado: (2021)

The Impact Of Hyperuricemia On Cardiometabolic Risk Factors In Patients With Diabetes Mellitus: A Cross-Sectional Study
por: Gaita L, et al.
Publicado: (2019)

Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus
por: Jevtovic F
Publicado: (2021)

Vitamin B12 Deficiency and Foot Ulcers in Type 2 Diabetes Mellitus: A Case–Control Study
por: Badedi M, et al.
Publicado: (2019)

Validation and cross-cultural adaptation of the depression Patient’s Health Questionnaire – 9 in the Romanian population of patients with Type 2 Diabetes Mellitus
por: Lupascu N, et al.
Publicado: (2019)

Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
por: Leng W, et al.
Publicado: (2021)

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
por: Schwartz SS, et al.
Publicado: (2016)

Dissolution Profile Evaluation of Eight Brands of Metformin Hydrochloride Tablets Available in Jimma, Southwest Ethiopia
por: Umeta B, et al.
Publicado: (2021)

Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes
por: Schweighofer N, et al.
Publicado: (2020)

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
por: Kuecker CM, et al.
Publicado: (2016)

La vitamina B12 no modifica la evolución de la anemia del prematuro
por: Mena N.,Patricia, et al.
Publicado: (2001)

Could ferritin, vitamin B12, and vitamin D play a role in the etiopathogenesis of fibromyalgia syndrome?
por: Kucuk Adem, et al.
Publicado: (2021)

Prevalence of Anemia and Its Associated Factors Among Adult Diabetes Mellitus Patients at Debre Tabor General Hospital, Northcentral Ethiopia
por: Engidaw MT, et al.
Publicado: (2020)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
por: Tangjarusritaratorn T, et al.
Publicado: (2021)

Anemia in patients with type 1 diabetes mellitus
por: Tatiana Yur'evna Kufelkina, et al.
Publicado: (2010)

Etiological causes of pancytopenia: A report of 137 cases
por: Osman Yokus, et al.
Publicado: (2016)

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
por: Hassoun AAK, et al.
Publicado: (2016)

Dynamics of Epicardiac Fat and Heart Function in Type 2 Diabetic Patients Initiated with SGLT-2 Inhibitors
por: Braha A, et al.
Publicado: (2019)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Moses R
Publicado: (2010)

Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010)

A Comparison Between the Therapeutic Effect of Metformin Alone versus a Combination Therapy with Insulin in Uncontrolled, Non-Adherence Patients with Type 2 Diabetes: Six Months Follow-Up
por: Paczkowska A, et al.
Publicado: (2021)

Metformin and Malignant Tumors: Not Over the Hill
por: Leng W, et al.
Publicado: (2021)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holl, et al.
Publicado: (2014)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
por: I Yu Demidova, et al.
Publicado: (2009)

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes
por: Conway BN, et al.
Publicado: (2018)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
por: Irons BK, et al.
Publicado: (2014)

The role of metformin in the modern strategy of treatment and prevention of type 2 diabetes mellitus
por: Olga Mikhailovna Smirnova
Publicado: (2010)

Multidimensional effects of metformin in patients with type 2 diabetes
por: Lyudmila A. Ruyatkina, et al.
Publicado: (2017)

Anemia among Adult Diabetic Patients Attending a General Hospital in Eastern Ethiopia: a Cross-sectional Study
por: Tujuba T, et al.
Publicado: (2021)